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doi:10.1016/j.numecd.2010.01.009Abstract Background and aims: Public health campaigns recommend increased fruit
and vegetable (FV) consumption as an effective means of cardiovascular risk reduction.
During an 8 week randomised control trial among hypertensive volunteers, we noted signif-
icant improvements in endothelium-dependent vasodilatation with increasing FV consump-
tion. Circulating indices of inflammation, endothelial activation and insulin resistance
are often employed as alternative surrogates for systemic arterial health. The
responses of several such biomarkers to our previously described FV intervention are re-
ported here.
Methods and results: Hypertensive volunteers were recruited from medical outpatient
clinics. After a common 4 week run-in period during which FV consumption was limited
to 1 portion per day, participants were randomised to 1, 3 or 6 portions daily for 8 weeks.
Venous blood samples for biomarker analyses were collected during the pre and post-inter-
vention vascular assessments. A total of 117 volunteers completed the 12 week study. Inter-
vention-related changes in circulating levels of high sensitivity C-reactive protein (hsCRP),
soluble intracellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion mole-
cule-1 (sVCAM-1), von Willebrand factor (vWF) and plasminogen activator inhibitor-1 (PAI-
1) did not differ significantly between FV groups. Similarly, there were no significant
between group differences of change in homeostasis model assessment (HOMA) scores.d Metabolism Group, Centre for Public Health, Lower Ground Floor, Pathology Building, Grosvenor
4 2890 632585; fax: þ44 2890 235900.
c.uk (D.O. McCall).
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The effect of increased dietary fruit and vegetable consumption 659Conclusions: Despite mediating a significant improvement in acetylcholine induced vasodila-
tation, increased FV consumption did not affect a calculated measure of insulin resistance
or concentrations of the circulating biomarkers measured during this study. Functional
indices of arterial health such as endothelium-dependent vasomotion are likely to provide
more informative cardiovascular end-points during short-term dietary intervention trials.
ª 2010 Elsevier B.V. All rights reserved.Introduction
A wealth of prospective epidemiological evidence has
linked increased fruit and vegetable (FV) consumption with
reduced rates of ischaemic heart disease [1] and stroke [2].
Although observational nutritional studies are often criti-
cised [3], both British [4] and American [5] guidelines
recommend increased dietary FV content as an effective
means of cardiovascular risk reduction. In a recent dietary
intervention trial, we described improved endothelium-
dependent vasodilatation among hypertensive volunteers
randomised to increased FV consumption [6]. While fore-
arm blood flow response to intra-arterial acetylcholine is an
established predictor of cardiovascular morbidity [7], the
technique remains invasive, labour-intensive and unsuit-
able for use during larger, multicentre trials.
Measurement of relevant, informative biomarker
concentrations within venous blood and/or urine may be
a potentially useful alternative. The American Heart Asso-
ciation (AHA) has recognised high sensitivity C-reactive
protein (hsCRP) as a risk stratification tool [8] and recent
data suggest that hsCRP reduction by statin therapy is an
effective primary prevention strategy among individuals
with favourable lipid profiles [9].
Intercellular adhesion molecule-1 (ICAM-1) and vascular
cell adhesion molecule-1 (VCAM-1) are thought to play
important roles in mediating leukocyte infiltration of the
evolving atherosclerotic plaque [10]. Activated or injured
endothelial cells shed ICAM-1 and VCAM-1 into the circula-
tion and plasma concentrations of these molecules inde-
pendently predict incident coronary heart disease in
healthy populations [11,12].
In addition to its vital role in normal haemostasis, the
circulating glycoprotein Von Willebrand factor (vWF) is
recognised as a useful marker of endothelial integrity [13].
During a 16 year follow-up, healthy men with higher serum
vWF concentrations were significantly more likely to suffer
a myocardial infarction [14].
The endothelium-derived serine protease plasminogen
activator inhibitor-1 (PAI-1) inhibits endogenous fibrinolysis
and elevated plasma levels have been associated with an
increased incidence of heart attack and stroke [15]. A
significant negative correlation between plasma PAI-1
levels and brachial flow-mediated dilatation among healthy
volunteers has also been described [16].
Oxidation both contributes to and follows on from the
continuous cycle of low-grade vascular inflammation which
characterises atherosclerotic arterial degeneration [17].
Isoprostanes are derived from the non-enzymatic perox-
idation of arachidonic acid and have become a popular,
widely employed measure of systemic oxidative stress in
cardiovascular disease [18].Using stored blood and urine samples we examined the
effects of an 8 week FV intervention on these markers of
inflammation, endothelial activation and oxidative stress.
In addition, since cross-sectional data has linked dietary
patterns characterised by high fruit and vegetable
consumption with improved insulin sensitivity [19,20],
a measure of insulin resistance was calculated pre and post-
intervention.
Methods
Details of this randomised dietary intervention trial have
been published elsewhere [6]. Briefly, volunteers with
brachial blood pressure in the range 140e190/90e110mmHg
were recruited from medical outpatient clinics. Following
a common 4week run-in period duringwhich FV consumption
was limited to 1 portion/day, participants were randomised
to 1, 3 or 6 portions daily for the next 8 weeks. Compliance
with the prescribed allocation was assessed using a series of
contemporaneously completed 4-day food diaries. Vascular
health was assessed immediately before and after this 8
week period. Patients attended a dedicated clinical
research facility between 8 and 9 am having fasted from
midnight the previous evening. They were also asked to
refrain from caffeine, alcohol and smoking for at least 12 h
pre-testing. Following 15 min supine rest, brachial blood
pressure was measured and a 30 mL venous blood sample
collected from the dominant arm. Volunteers then provided
a spot urine sample before arterial cannulation and venous
occlusion plethysmography.
All blood and urine samples were processed and frozen
at 80 C within 2 h of collection.
High sensitivity CRP levels were determined in serum
using an immunoturbidimetric assay (Randox, Crumlin,
Northern Ireland) on the ILab-600 biochemical analyser
(Instrumentation Laboratories, Warrington, UK). Plasma
concentrations of soluble ICAM-1 (sICAM-1) and (sVCAM-1)
were determined using enzyme linked immunoassay (ELISA)
kits (ImmunoDiagnostic Systems Ltd, Boldon, England). A
Triturus analyser with dedicated software (Grifols Diag-
nostics, Barcelona, Spain) was used for all ELISA analyses.
An immunoturbidimetric assay (STA-Liatest, Diagnostica
Stago, Asnieres, France) was used in the Regional Coagu-
lation Laboratory (Belfast City Hospital), to quantify
plasma levels of vWF antigen. Intra and inter-assay CVs
were <15%. PAI-1 was assessed using a sandwich ELISA
assay (Trinity Biotech, Wicklow, Ireland) on an automated
ELISA system.
Total urinary F2-isoprostane concentrations were
measured as an estimate of systemic oxidative stress using
the method outlined by Roberts and Morrow [21]. Following
extraction, derivatized spot urine samples were analysed
660 D.O. McCall et al.by gas chromatography-mass spectrometry using a Trace GC
Ultra e DSQ II MS system (Thermo Fisher Scientific, Massa-
chusetts, USA). The intra-assay CV for this technique was
<12%. Total F2-isoprostane content was standardised for
urinary creatinine. The latter was measured using an
enzymatic method (Randox, Crumlin, Northern Ireland) by
automated colorimetric laboratory analysis (ILab-600,
Instrumentation Laboratories, Warrington, UK).
Glucose was measured in serum by enzymatic colori-
metric assay on a Roche modular analyser (Roche Diagnos-
tics Ltd, West Sussex, UK). Insulin was measured in serum
using Micro particle Enzyme Immunoassay (MEIA) tech-
nology (Abbott Laboratories, Berkshire) on an Abbott IMX
analyser.
A measure of insulin resistance was derived from fasting
glucose and insulin using the homeostasis model assessment
(HOMA, fasting glucose (mmol/l)  fasting insulin (mmol/l)/
22.5) in which higher scores denote low insulin sensitivity
[22].
Statistical analysis
The principle analysis for each variable was a between
intervention group comparison of change using 1-way anal-
ysis of variance (ANOVA). The relationship between endo-
thelium-dependent vasodilatation as defined by maximum
response to acetylcholine and each biomarker measured at
baseline was assessed using Pearson’s correlation coeffi-
cients. The same approach was used to compare change in
maximum response to acetylcholine with change in each
biomarker. Non-parametric variables were log-transformed
prior to analysis. All tests were 2-tailed and p < 0.05 was
considered significant. Analyses were performed using SPSS
version 17.0.1 (SPSS Inc. Chicago, IL).
As outlined previously a power calculation was per-
formed based on the primary endpoint, endothelium-
dependent vasodilatation [6].Table 1 Pre-intervention phase characteristics of 112 participa
1/day (n Z 33)
Age (years) 52.4(7.9)
Men (%) 70
BMI (kg/m2) 29.7(4.4)
Systolic blood pressure (mmHg) 139.4(15.0)
Diastolic blood pressure (mmHg) 82.0(11.9)
Current smokers (%) 39
Former smokers (%) 36
Antihypertensive therapy (%) 36
Lipid-lowering therapy (%) 52
Triglycerides (mmol/l)* 2.10(0.53)
Total cholesterol:HDL ratio 4.37(1.35)
Serum glucose (mmol/l)* 6.02(1.40)
Serum insulin (mmol/ml)* 10.67(15.60)
Fruit and vegetable
intake (portions/day)*
0.9(0.3)
For all variables nZ 33; 39; 40 for the 1-;3-;6-portions/day groups res
where n Z 32; 39; 38. Continuous variables are summarised as mea
a geometric mean with interquartile range is quoted.Results
A total of 147 eligible individuals initially agreed to take
part in this study. There were 29 dropouts during the
common 1 portion/day run-in phase. Only 1 volunteer failed
to complete the 8 week intervention meaning that a total
of 117 participants attended for vascular assessment on 2
occasions. Five individuals had pre-intervention serum
hsCRP concentrations >10 mg/L which in accordance with
AHA guidelines [8] were interpreted as consistent with
active infection or inflammation, prompting exclusion of
those volunteers from further analyses.
Throughout the 12 week trial period, participants were
asked to minimise changes in other health and lifestyle
behaviours. Both they and their general practitioners were
asked to inform study investigators about any newly
prescribed medications.
Baseline characteristics
Pre-intervention characteristics of the remaining 112
participants according to FV allocation are summarised in
Table 1. There were no statistically significant differences
between groups at baseline. Data from 4-day food diaries
completed during the common 1 portion/day run-in period
suggest good compliance with the washout.
Intervention-associated changes in markers of
inflammation, endothelial activation and oxidative
stress
Concentrations of hsCRP, ICAM-1, VCAM-1, vWF, PAI-1,
urinary F2-isoprostane and HOMA scores are summarised in
Table 2. Despite increases in reported FV consumption and
accompanying changes in biomarkers of FV consumption [6],
indicating good compliance with the intervention, therents according to daily fruit and vegetable allocation.
3/day (n Z 39) 6/day (n Z 40)
56.1(8.4) 53.7(7.1)
62 63
28.2(3.2) 28.8(3.3)
144.6(18.1) 145.3(15.7)
81.1(11.1) 86.3(11.0)
3 15
44 35
46 63
67 55
1.75(1.54) 1.56(1.43)
4.18(1.45) 4.31(1.31)
5.98(0.95) 5.82(0.97)
8.27(3.90) 8.76(8.67)
1.0(0.5) 1.1(0.6)
pectively, except for triglycerides, cholesterol:HDL ratio and CRP,
n  standard deviation except for * where data is skewed and
Table 2 Biomarker concentrations following the run-in (pre) and intervention (post) phases with p values from between group
comparisons of change by one-way ANOVA for each variable.
1/day n Z 29 3/day n Z 35 6/day n Z 34 p for
ANOVAPre Post Pre Post Pre Post
hsCRP (mg/l) 2.03(1.29) 1.90(1.87) 1.71(1.56) 1.39(1.04) 1.49(1.08) 1.47(1.42) 0.95
ICAM-1 (ng/ml) 692(358) 698(318) 605(203) 583(202) 545(189) 572(189) 0.44
VCAM-1 (ng/ml) 779(343) 713(306) 803(341) 672(253) 696(368) 653(268) 0.25
vWF (IU/ml) 0.92(0.46) 0.93(0.57) 1.00(0.27) 1.00(0.40) 0.91(0.31) 0.93(0.30) 0.99
PAI-1 (ng/ml) 58.30(28.19) 58.58(35.29) 50.20(29.05) 50.33(21.09) 48.43(34.86) 53.06(35.68) 0.35
F2-Isoprostane: creatinine
(ng/mg)a
1.63(1.09) 1.40(1.65) 1.09(0.93) 1.07(1.39) 1.44(1.24) 1.31(1.22) 0.29
HOMA Score 2.86(3.70) 2.90(3.00) 2.20(1.29) 2.52(1.81) 2.41(2.55) 2.64(2.79) 0.27
Fruit and Veg consumption
(portions/day)
0.9(0.3) 1.1(0.5) 1.0(0.5) 3.2(0.8) 1.1(0.6) 5.6(0.9) <0.01
b-cryptoxanthin (mmol/l) 0.05(0.05) 0.05(0.04) 0.06(0.05) 0.07(0.09) 0.07(0.07) 0.11(0.10) <0.001
Lutein (mmol/l) 0.13(0.07) 0.14(0.07) 0.15(0.08) 0.17(0.11) 0.16(0.08) 0.20(0.12) 0.002
VitaminC (mmol/l) 23.7(18.8) 25.8(18.9) 25.7(15.8) 38.9(24.3) 27.9(25.8) 42.3(28.1) 0.06
All variables are summarised as geometric mean (interquartile range).
hsCRP e High sensitivity C-reactive protein, ICAM-1 e Intercellular adhesion molecule-1, VCAM-1 e Vascular cell adhesion molecule-1,
vWF e von Willebrand factor, PAI-1 e Plasminogen activator inhibitor-1, HOMA e Homeostasis model assessment.
a For spot urine samples n Z 28, 35 and 34 for 1, 3 and 6-portions/day respectively.
The effect of increased dietary fruit and vegetable consumption 661were no significant between group differences in change
for any of the biomarkers measured. Similarly, the inter-
vention did not alter insulin resistance as assessed by HOMA
scores.
Relationship between biomarkers and
endothelium-dependent vasodilatation
At baseline, a significant negative correlation was noted
between HOMA score and maximum response to acetyl-
choline (rZ 0.247, pZ 0.012). No significant correlations
were noted between change in maximum response to
acetylcholine over the course of the intervention and
change in any of the biomarkers measured (Table 3).
Discussion
Despite mediating improved endothelium-dependent vaso-
dilatation, increased FV consumption over an 8 week periodTable 3 Relationship between baseline/intervention-associated
change in biomarker.
Variablea Correlation coefficient
at baseline
hsCRP 0.11
sICAM-1 0.03
sVCAM-1 0.10
vWF 0.10
PAI-1 0.08
Urinary F2-isoprostane 0.10
HOMA score 0.25
hsCRP e High sensitivity C-reactive protein, ICAM-1 e Intercellular ad
vWF e von Willebrand factor, PAI-1 e Plasminogen activator inhibitor
a In each case the differences between log-transformed variables wdid not significantly alter the circulating concentrations of
hsCRP, ICAM-1, VCAM-1, vWF, PAI-1, change urinary F2-iso-
prostane excretion or improve insulin sensitivity as assessed
by HOMA score. Although this was not a controlled feeding
study, 4-day contemporaneous food diary data and appro-
priate increases among selected circulating micronutrient
concentrations suggested good compliance with the
prescribed dietary intervention.
Cross-sectional studies, largely employing food
frequency questionnaires, continue to associate higher FV
intake with lower serum levels of hsCRP [23,24]. In a study
similar to the current work, 64 healthy volunteers
consumed either 2, 5 or 8 portions of carotenoid-rich FV
daily for 4 weeks [25]. Between group-comparisons of
change in serum hsCRP showed a significantly greater
reduction among those eating 8 portions/day. Participants
in Watzl et al’s study were healthy, exclusively male, non-
smokers who habitually consumed up 4e5 servings of fruit
and vegetables daily and thus direct comparisons with the
current study are difficult.change in maximum response to acetylcholine and baseline/
p Correlation coefficient
for change
p
0.28 0.11 0.28
0.71 0.46 0.65
0.31 0.01 0.89
0.31 0.08 0.42
0.41 0.05 0.42
0.33 0.17 0.87
0.01 0.01 0.92
hesion molecule-1, VCAM-1 e Vascular cell adhesion molecule-1,
-1, HOMA e Homeostasis model assessment.
ere compared.
662 D.O. McCall et al.Short-term dietary FV intervention trials in cohorts at an
increased cardiovascular risk have generally reported
negative findings when hsCRP is employed as an endpoint
[26e28]. This lack of effect on CRP is also shown in other
dietary intervention studies where significant improve-
ments in a functional vascular measure are reported.
Among volunteers with abdominal obesity, a 2 month
Mediterranean diet, which included a significant increase in
FV consumption, significantly improved flow-mediated
dilatation (FMD) of the brachial artery but failed to change
serum hsCRP [29]. Similar results have been reported for a 5
week soy-diet intervention in renal transplant patients
[30]. While trials designed to produce weight loss describe
associated reductions in plasma PAI-1 concentrations
[31,32], more specific dietary interventions (for example,
with fatty acids or Mediterranean diet) have generally
failed to alter either fibrinolytic parameters or circulating
vWF levels [33,34]. When 112 volunteers at increased
cardiovascular risk were randomised to a low-fat or Medi-
terranean diet for 3 months, significantly reduced concen-
trations of plasma sICAM-1 and sVCAM-1 were observed in
the latter group [35]. Investigators have also reported
down-regulation of these adhesion molecules following 4
week red wine [36] and 8 week soy nut interventions [37].
Such positive findings contrast with those reported here and
may be related to a number of factors. Mena and colleagues
studied more comprehensive dietary revisions, for longer
intervention periods, in a cohort where the prevalence of
type 2 diabetes approached 70% [35]. The red wine and soy
nut studies recruited medication-naive, healthy volunteers
while again employing a more specific test-intervention.
Investigators have reported that urinary levels of F2-
isoprostane were significantly reduced among healthy
women consuming 9e10 portions of fruit and vegetables
daily for 8 weeks [38]. Since these investigators recruited
non-smoking, medication-free volunteers from a womens’
health group, extrapolation to the current cohort is diffi-
cult. It remains possible, however, that 6 FV portions daily
is an insufficient quantity to significantly reduce systemic
oxidative stress. While significant reductions in plasma
isoprostane concentrations have been reported following
a 14 day FV soup intervention among 12 healthy volunteers,
these findings have not been replicated in larger, longer
studies employing fruit [39], antioxidant [40], and flavo-
noid-rich food [41] supplementation.
A previous study examining the effects of regular black
tea consumption among healthy volunteers noted improved
brachial flow-mediated dilatation without any change in
urinary isoprostane excretion [42]. This is perhaps unsur-
prising since cross-sectional research describes generally
poor correlations between endothelium-dependent forearm
blood flow and isoprostane concentrations in urine [43].
Italian investigators have reported that randomisation to
a Mediterranean diet, which included higher FV content,
significantly reduced HOMA scores among volunteers ful-
filling ‘metabolic syndrome’ criteria [44]. This 24 month
intervention was much longer than that presented here and
also mediated significant improvements in weight and blood
pressure. A recent 4 week plant-based low carbohydrate
dietary intervention in dyslipidaemic patients was charac-
terised by increased FV consumption but failed to signifi-
cantly alter HOMA scores [45].The relationship between reduced endothelium-depen-
dent vasodilatation and impaired glucose tolerance has
been well described [46] and thus our finding of a significant
negative correlation between HOMA score and maximum
response to acetylcholine is not surprising. Changes in these
parameters were not related however, suggesting that FV-
associated improvements in endothelium-dependent vaso-
dilatation are not mediated by enhanced insulin sensitivity.
Alternatively, a more sensitive test of glucose tolerance,
such as the euglycaemic clamp technique, may be neces-
sary to further explore this hypothesis.
The current work did not exclude volunteers prescribed
regular antihypertensive or lipid-lowering therapy and it is
possible that these agents may have masked any effect of
FV consumption on biomarker concentrations. Equally, to
increase the clinical and public health applicability of our
findings, a controlled feeding approach was not employed
and it remains possible that additional, non-prescribed,
dietary or lifestyle intervention-associated changes
occurred. Circulating salicylic acid concentrations have
recently been shown to have a significant positive correla-
tion with fruit and vegetable consumption among healthy
volunteers who were not taking aspirin [47]. This inter-
esting observation suggests that salicylic acid measurement
may prove useful when considering future studies to
examine the relationship between diet and systemic
inflammation.
Short-term intervention studies which employ surro-
gate end-points to detect a biological effect are per-
formed frequently in cardiovascular research. The current
findings suggest that increased FV consumption does not
alter circulating hsCRP, sICAM-1, sVCAM-1, vWF, PAI-1 or
urinary isoprostane concentrations. These biomarkers
appear dissociated from the observed improvements in
endothelium-dependent vasodilatation and are thus
unlikely to serve as informative measures for future
similar studies.
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